Mominul Islam
Ispahani Islamia Eye Institute And Hospital
Tealangiectesia
Decrease Visual acuity
Intraretinal
Corneal Oedema
exudation
Strabismus
Exudative RD
Leukocoria
Partial RD
Heterochromia
Total RD
Iris neovascularization
Retinal hemorrhage
Retinal macrocyst
Ophthalmoscopic picture
Staging of Coats Disease
Am J Ophthalmol 2001;131:572–83
Systemic conditions
• Muscular dystrophy
• Turner syndrome
• Alport syndrome
• Aplastic anemia
Ocular conditions that can
simulate
Juvenile Coats disease At any age
• Laser photocoagulation
• Cryotherapy
• Surgical Intervention
Repair Traction
Hemorrhage
RRD
USE of PDT in combination with IVB for adult coats.
disease
Ablative therapies
Laser
LaserPhotocoagulation
Photocoagulation Cryotherapy
••Less
Lesssevere
severecases
casesof
of • Laser is ineffective
exudation
exudation • Extensive sub-retinal
••With
Withororwithout
withoutRD
RD exudation
••Vascular
Vascularleakage
leakage • RD
••Non
Nonperfusion
perfusion • Drain sub retinal
••NVE
NVE exudation
Pharmacologic therapies
Intravitreal Triamcinolone acetonide
Effective in macular Oedema
Sub retinal exudation
Intravitreal Anti VEGF
• Surgical Intervention
Repair Traction
Hemorrhage
RRD
End stage NVE
Painful Blind eye
Outcome
• Telangiectesia resolved (mean interval 15 months following
treatment)
Completely 47%
Partially 53%
• Inactive telangiectesia and Old exudation (17 months following
Treatment)- 45%
• Recurrence of Leakage and New telangiectesia (in 10 years)-7%
• Most cases
Stabilize /Improve- 76%
Progressively worsening -8%
Required Enucleation – 20%
Take Home Massage
• Coats disease is a serious eye disease
• Repeated treatment are needed to stabilize
the affected eyes
• Lifelong and serial monitoring required.
• Careful distinction of coats disease from
retinoblastoma is important